Locations:
Search
Targeted mRNA blocking could be first effective approach specific to this cardiovascular risk factor
First U.S. implant at Cleveland Clinic signals another key shift away from transvenous leads
Essentials of the NIH study and how it compares with REPAIR MR
How to time the interventions, and how to manage anesthesia risks?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Innovative construct restores function after resection of softball-size chondrosarcoma
Interim report from large registry analysis compares favorably with pivotal trial
Both sexes, but especially women, stand to benefit from adding it to echo
Most are slow-growing and can safely be monitored every three years
Two-day procedure prevents neurologic compromise for octogenarian
Also, earlier surgery likely benefits patients with severe functional TR
Advertisement
Advertisement